Concepedia

Tom Seijkens

TS

33

Publications

2.6K

Citations

24

H-Index

2010

Active since

Affiliations

Ludwig-Maximilians-Universität München(Current)

University of Amsterdam

Maastricht University

Amsterdam UMC Location University of Amsterdam

Amsterdam University Medical Centers

Tom Seijkens is an author at Ludwig-Maximilians-Universität München specializing in medicine, immunology, and inflammation.

ORCID

Top concepts

Publications per year

2010–2024

33

Publications

33

Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis

Dirk Lievens, Alma Zernecke, Tom Seijkens et al. · Blood · 2010 · 291 citations · Full text

Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile

Esther Lutgens, Dirk Lievens, Linda Beckers et al. · The Journal of Experimental Medicine · 2010 · 241 citations · Full text

, , +20

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis

Tom Seijkens, Claudia M. van Tiel, Pascal Kusters et al. · Journal of the American College of Cardiology · 2018 · 187 citations · Full text

Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions

Marten A. Hoeksema, Marion J. Gijbels, Jan Van den Bossche et al. · EMBO Molecular Medicine · 2014 · 175 citations · Full text

Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis

Kikkie Poels, Mandy M. T. van Leent, C. Boutros et al. · JACC CardioOncology · 2020 · 132 citations · Full text

Rows per page

1–5 of 33